Phase II Study of Durvalumab in Combination With Lenalidomide in Relapsed/Refractory NK-T-cell Lymphoma
Clinical trial NCT03054532 · UNKNOWN
Trial details
- NCT number
- NCT03054532
- Sponsor
- Singapore General Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-01
- Primary completion
- 2021-01-01
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.